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Abstract 
 
Aqueous ethanol (80%) extracts of six plants used traditionally for treatment of malaria, Vepris 
glomerata (F.Hoffm.) Engl (Rutaceae), Maranthus floribunda (Bak.) F.White (Chrysobalanaceae), 
Strophanthus eminii Asch. & Pax ex Pax (Apocynaceae), Cassia abbreviata Oliv. (Leguminosae) and 
Caesalpinia bonducella L. Fleming (Fabaceae) were screened for antimalarial activity to establish 
validity of their claims. The extracts exhibited antimalarial activity in the 4-day Peter’s suppressive 
antimalarial assay in mice inoculated with red blood cells parasitized with Plasmodium berghei. The 
extracts gave ID50 values of 42.8, 111.0, 639.3 and 1560 mg/kg body wt for C. bonducella, C. 
abbreviata, T. furialis and S. eminii, respectively. The ID50 values for V. glomerata and M. floribunda 
were above 2400 mg/kg body wt, above which point solubility was a problem. All the tested extracts 
were innocuous to the mice, up to 2400 mg/kg body wt, suggesting they may be safe for short-term use.  
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Introduction 
 
Malaria is the leading cause of morbidity and mortality in sub-Saharan Africa, especially in 
young children and pregnant women (UNICEF, 2004). Compounding the problem are other factors that 
include environmental changes, the collapse of health systems in areas of civil strife and war, resistance of malaria 
parasites to affordable anti-malarial drugs and limitations in national health services (Nsimba, 2006). Recently, a 
number of studies and campaigns have been done for the adoption of artemisinin combination therapies 
(ACTs) (Sutherland et al., 2005; Attaran, 2004; Duffy and Mutabingwa, 2005), which have now been 
adopted in a number of countries including Tanzania. However, the slowly eliminated partner drugs in ACTs 
may soon or later, be susceptible to development of resistance in high endemic settings (Kremsner and Krishna, 
2004; Talisuna et al., 2004). Signs of in vitro resistance to some artemisinins (Jambou et al., 2005; Uhlemann et al., 
2005; Sisowath et al., 2007), already being observed emphasize the need to increase efforts to develop new 
antimalarials, to provide future therapeutic options. 
 
This study aimed to validate six traditionally used plants, in Tabora and Dar es Salaam 
(Tanzania), for their efficacy in the treatment of malaria as further follow-up in their development and 
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use for managing malaria infections. The current study reports the invivo activity of aqueous ethanolic 
extracts of the plants. 
 
 
Materials and Methods 
Solvents 
 
Dimethyl sulphoxide (DMSO) was purchased from Sigma (Poole, Dorset, UK), ethanol from Fisher 
Scientific UK Ltd (Bishop Meadow Road, Loughborough, Leicestershire, LE 11 5RG, UK).  
Carboxymethylcellulose (CMC) was purchased from BDH chemical Ltd (Poole, UK) and Saline was purchased from 
Claris Lifescience Ltd, (Ahmedabad-382 213, India).
 
 
Plant information and collection details 
 
Five of the plants were collected in September, 1999 in Tabora and one is among collections 
done in the Coast region in 2006 (Table 1), and all were identified by Mr. Selemani Haji (Botany 
Department, University of Dar es Salaam). Voucher specimens are kept in the Herbarium of the Institute 
of Traditional Medicine, MUHAS. 
 
Preparation of plant extracts 
 
Air-dried powdered plant materials (150-200g) were extracted with 80% ethanol (1L), for 72h at room 
temperature, twice, to ensure exhaustive extraction. The filtrates were concentrated under reduced pressure, 
in vacuo, followed by removal of residual water by freeze-drying. Extract yields of between 0.25-7.5% were 
obtained. The extracts were stored in a freezer, at -20OC, until needed for testing. On test day the extracts were 
suspended in a 3:7 mixture of DMSO and 1% carboxymethylcellulose (CMC).  
 
In vivo antiplasmodial testing 
Parasite strain 
 
In vivo antimalarial testing in mice was done using chloroquine sensitive strain of Plasmodium 
berghei berghei (Obtained from the National Institute for Medical Research, NIMR). The parasite stock 
was maintained by continuous re-infection in the mice. 
 
Animals 
 
Male and female Theiller’s original white albino mice (20-32 g), used in the study were kept in 
an air-conditioned room, and fed ad libitum with food and water during the whole period of the study. 
The study obtained approval from the University Ethical Review Committee, and in accordance to the 
National Guidelines for handling laboratory animals. 
 
 Inoculum 
 
Four donor mice were injected with a chloroquine sensitive strain of Plasmodium berghei, and parasitaemia allowed 
to build up for three days, at which point blood smears were taken. Blood smears were taken on the third day, and the 
mice only used after ensuring that 30-40 % parasitaemia was attained. After anaesthesia with chloroform, 0.5ml of 
blood were drawn through the eye vein with heparinized syringe, transferred into a  screw capped sterile plastic 
tube and then topped up to14 ml with normal saline. Each mouse was injected intra-peritoneally (ip) with 0.2ml 
of the suspension (107 infected red blood cells).  
Four day suppression test 
             Peters’ 4-day suppressive test against P. berghei infection was used (Peters et al, 1975). After 3-hrs of 
infection with parasites, the mice were randomly assigned into treatment groups of five. One group was given 5 
ml/kg body wt 30% DMSO in 1% CMC, one group was given chloroquine (10 mg/kg body wt) and the remaining 
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groups were given between 25 - 2400 mg/kg body wt of 80% ethanolic extracts of the plants, with intermediate doses 
interpolated using a log scale. The extracts were administered orally once daily for four consecutive days.  
Determination of parasitaemia 
 
            Percentage suppression of parasitaemia was calculated using the following formula:     
% Suppression = Parasitaemia in negative control - Parasitaemia in study group                                                                                                               
Parasitaemia in negative control 
 
Calculations for ID50 
 
The mean results of percentage suppression of parastaemia against the logarithms of doses were plotted 
using the Fig P computer program (Biosoft Inc, USA), which also gives the regression equations. The regression 
equations were used to calculate ID50 values. 
 
Acute toxicity testing  
 
An acute assessment of toxicity was performed to ascertain the lethality and potency of the extracts. Mice 
were divided into groups of 10, and starved for 24 hrs, before the experiment began with only water allowed. On the 
next day the two groups were given solvent and 2400mg/kg body wt, respectively. The mice were observed for 24 h. 
Assessment was only done for survival at the 24 h time point. 
 
 
 
Results and Discussion 
 
Table 1 shows the general information on the plants used in this study and the reasons that prompted us to 
test them for antimalarial activity. The antimalarial activity of Tragia fuliaris, Maranthes floribunda, Vepris 
glomerata and Strophanthus eminii are reported for the first time while the invitro antimalarial activity of
 Cassia 
abbreviata and Caesalpinia bonducella are available in the literature (Spencer et al., 1947; Addae Kyereme and 
Wright, 1997; Mukerji et al., 1943; Weenen et al., 1990). It was noted that the most active extract was Caesalpinia 
bonducella root extract (ID50 42.8 mg/kg body wt), followed by Cassia abbreviata leaf extract (ID50 111.0 
mg/kg/wt). Tragia furialis (ID50 = 639.3 mg/kg/wt) has good invivo antimalarial activity to support traditional 
claims. The ID50 values for Vepris glomerata and Maranthes floribunda extracts were above 2400 mg/kg body wt, 
and could not be estimated due to difficulty of solubility at higher concentrations. Chloroquine used as a positive 
control caused 93% suppression of parasitaemia at 10 mg/kg body wt. Four previous studies reported negative 
antimalarial results for extracts of Caesalpinia bonducella (Spencer et al., 1947; Addae Kyereme and Wright, 1997; 
Mukerji et al., 1943; Weenen et al., 1990), while one study reported weak antimalarial activity of dried stem ethanol 
extract (Simonsen et al., 2001). The present results suggest that the root 80% ethanol extract has potential to yield a 
compound/s with much higher activity. This is, however, the only study to use the invivo model to assess antimalarial 
activity of this plant. There are three previous studies on in vitro antimalarial activity of extracts of Cassia 
abbreviata leaves (Connelly et al., 1996) and roots (Gessler et al., 1996; Weenen et al., 1990). The leaf extract was, 
previously reported to have weak activity against Plasmodium falciparum (Connelly et al., 1996), while for the root 
only an ethyl acetate extract was active against Plasmodium falciparum (Gessler et al., 1994).  
The current results are the only reported in vivo results, that support the therapeutic claims by traditional 
healers, and the ID50 value recorded is good enough to warrant further studies to identify active fractions or 
compounds and in line with current practice, to explore possibility for use in a combination regime with other plant 
extracts or established antimalarial compounds. The extracts of the six plants used in this work were not toxic to 
mice following single dose administration up to 2400 mg/kg body wt; the highest dose used in this work. These 
results are in agreement with brine shrimp results, which showed that the 80% ethanol extracts of these plants 
exhibited low toxicity (Moshi et al., 2006). 
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Table 1. General information of the six plant materials 
Species Name 
(Family) 
Voucher 
No. 
Vernacular 
name 
(Tribe): 
Ethnomedical 
uses: 
Part used and 
preparation 
Cassia abbreviata 
Oliv.(Caesalpinicea
e)[ 
IMPP 002-
0037, 
Mlundalunda
/mzoka 
(Nyamwezi); 
HIV/AIDS, 
malaria; 
Fresh roots are dried, 
extracted and drunk 
three times a day 
Maranthes floribunda 
(Bak) F. White 
(Chrysobalanaceae) 
[IMPP 002-
0137; 
Msundwi 
(Nyamwezi) 
Malaria, 
psychosis, 
epilepsy 
Dried root powder is 
mixed with warm 
water or porridge and 
taken 2-3 times a 
day. 
Strophauthus eminii 
Asch. Pax 
(Apocynaceae) 
IMPP 002-
0013/002-
0096 
Ifumya 
(Nyamwezi); 
Malaria, 
epilepsy; 
The roots are 
powdered, and the 
powder administered 
by sniffing. 
Tragia fuliaris Boj 
(Euphorbiaceae) 
IMPP 002-
0126/002-
0071 
Mpugambu/
Kaboroja 
(Nyamwezi); 
Malaria, 
aphrodisiac, 
paralysis 
Dried roots extracted 
with cold water and 
one cup taken three 
times a day for three 
days. 
Vepris glomerata 
(F.Hoffm) Engl. 
(Rutaceae) 
IMPP 002-
0042 
Mlungusikiti 
(Nyamwezi); 
Psychosis, 
malaria, epilepsy, 
stroke; 
Dried root powder is 
extracted with cold 
water or mixed with 
tea and drunk thrice a 
day for 3 days. 
Caesalpinia 
bonducella 
L.(Fabaceae) 
ADSK 12 Msolo 
(Zaramo); 
Malaria, 
diabetes, 
gastrointestinal 
problems, 
convulsions, 
leprosy; 
Powdered dry leaves 
are boiled with water 
and taken 3 times a 
day. 
 
 
 
Conclusion 
 
The extracts of six plants used in traditional medicine to treat malaria exhibited in vivo antimalarial activity, 
but three had very weak activity. Caesalpinia bonducella root and Cassia abbreviata leaf ethanol extracts were the 
most promising for further work 
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